CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 250 enrolled
Drug / intervention
Ciprofloxacindrug
Likely dose
Ciprofloxacin 250 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03366207
NCT03366207Phase 4Completed
CompareCT.gov

Clinical and Microbiologic Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection in Adult Women.

Iterum Therapeutics, International Limited·interventional·Posted Dec 8, 2017·Updated Sep 6, 2019

In Brief

A Phase 4 clinical trial evaluating Ciprofloxacin for UTI - Lower Urinary Tract Infection and Antibiotic Resistant Infection. Completed, enrolled 250 participants across 1 site.

Detailed Summary

This is a prospective, Phase 4, open label, multi-center study of the clinical and microbiologic efficacy of ciprofloxacin for the treatment of uncomplicated urinary tract infections in adult women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUTI - Lower Urinary Tract Infection, Antibiotic Resistant Infection
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedDec 8, 2017
Enrollment StartDec 15, 2017
Primary CompletionJul 31, 2018
Study CompletionOct 26, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 8.6 years ago

Interventions

Ciprofloxacindrug

Ciprofloxacin 250 mg PO twice daily (BID) x 3 days for women with uUTI.